About Contact Us Careers
Sign In

Endoscopic Retrograde Cholangiopancreatography Market - Top Companies and Manufacturers

  • Report ID: 4859
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Companies Dominating the Endoscopic Retrograde Cholangiopancreatography Landscape

    • Boston Scientific Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Cook Medical LLC
    • Olympus Corporation
    • Conmed Corporation
    • Medtronic plc
    • Fujifilm Holdings Corporation
    • ERBE Elektromedizin GmbH
    • Steris plc
    • Karl Storz GmbH & Co. KG
    • Ethicon Endo-Surgery, Inc.
Browse Key Market Insights with Data Illustration:

In the News

  • Boston Scientific Corporation: Boston Scientific announced the launch of its EXALT Model D Single-Use Duodenoscope, which is the first and only FDA-cleared single-use duodenoscope on the market. The device is designed to eliminate the need for duodenoscope reprocessing and reduce the risk of infection transmission to patients.
  • Olympus Corporation: Olympus announced the launch of its PowerSpiral Endoscopic Ultrasound (EUS) system, which is designed to enhance the diagnosis of gastrointestinal (GI) disorders. The system features a rotating ultrasound transducer that provides high-resolution images of the GI tract, enabling physicians to detect small lesions and abnormalities that may have been missed with traditional EUS techniques.

Author Credits:  Radhika Pawar


  • Report ID: 4859
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of endoscopic retrograde cholangiopancreatography is estimated at USD 3.31 billion.

The endoscopic retrograde cholangiopancreatography market size was over USD 3.01 billion in 2024 and is projected to cross USD 14.1 billion by the end of 2037, witnessing more than 12.5% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of pancreatic and biliary diseases, along with the growing geriatric population will boost the market growth.

Asia Pacific industry is predicted to account for largest revenue share of about 35% by 2037, owing to increasing prevalence of pancreatic and biliary diseases in the region.

The major players in the market include Boston Scientific Corporation, Cook Medical LLC, Olympus Corporation, Conmed Corporation, Medtronic plc, Fujifilm Holdings Corporation, ERBE Elektromedizin GmbH, Steris plc, Karl Storz GmbH & Co. KG, Ethicon Endo-Surgery, Inc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample